Announcements Trials
Browse Landscape

Phase

Phase NA 59Phase 2 4Phase 2/3 2Phase EARLY_PHASE1 1Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Weight Loss 1Neoplasms 1Motor Activity 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Cachexia 1

Interventions

Gemcitabine 217Fluorouracil 141Oxaliplatin 131Capecitabine 122pembrolizumab 113Irinotecan 109Leucovorin 103Bevacizumab 98Nivolumab 80130-nm albumin-bound paclitaxel 80Cisplatin 79Cetuximab 79Radiotherapy 78Albumin-Bound Paclitaxel 59Sorafenib 56Paclitaxel 53Cyclophosphamide 49Carboplatin 47Magnetic Resonance Spectroscopy 43Specimen Handling 39Docetaxel 37Taxes 36Radiation 34fludarabine 33Ipilimumab 33Erlotinib Hydrochloride 33durvalumab 32Biopsy 32Folfox protocol 28Radiosurgery 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Exercise × Gastrointestinal × Clear all
NCT04131426 2023-08-15

Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia

University of Rochester

Phase 1 Completed
25 enrolled
GastrointestinalThoracic

Cachexia, Gastrointestinal Neoplasms, Lung Neoplasms, Motor Activity, Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡